- Home
- About
- Section Advisors
- Meet Our Field Medical Affairs Team
- Speakers Bureau
- Supporting Organizations
- Contact Us
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Attention Deficit Hyperactivity Disorder (ADHD)
- Bipolar Disorder
- Depression
- Pseudobulbar Affect (PBA)
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Infographics
- Learning Tracks
- Podcasts
- Shareable/Downloadable Content
- Videos
- PsychUSim
- PsychU Roleplay
- Frameworks In Health & Quality Resources
- Mental Health System Guidebooks
- Psychiatric Scales
- Psychopharmacology
- Supporting Organizations
Virtual Event – Management of Major Depressive Disorder: Breaking Through the Barriers
Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Virtual Event – Management of Major Depressive Disorder: Breaking Through the Barriers
In this presentation, the objectives are to:
- To understand that Major Depressive Disorder (MDD) is a serious illness leading to decreased overall patient health and quality of life
- To investigate the effect of inadequate treatment response in MDD on patients and their families
- To recognize predictors of and important considerations for inadequate treatment response in MDD, including the new DSM-5 specifier for anxious distress
- To consider the importance of proactive treatment decisions
Featuring
David Purselle, MD
Board-certified psychiatrist with over 20 years of clinical experience, Director of Georgia Psychiatric Consultants and an adjunct faculty member at Morehouse School of Medicine
MoreDr. David Purselle is a board-certified psychiatrist with over 20 years of clinical experience working in a variety of settings, including outpatient clinics, emergency rooms, and inpatient units at the Atlanta VA Medical Center, Emory University Hospital, and Grady Hospital. Currently, he is the Director of Georgia Psychiatric Consultants and an adjunct faculty member at Morehouse School of Medicine. He is also involved with several clinical research studies studying the effectiveness of various antidepressants, mood stabilizers, antipsychotics, and lithium. Dr. Purselle has been recognized as a physician leader in several forums and presented continuing medical education programs at national and local conferences. He has also served as a consultant for major pharmaceutical corporations providing guidance on development of new therapies for a variety of mental illnesses.
Kayci Criss, PharmD
David Purselle, MD is a speaker for Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
Kayci Criss, PharmD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
Related Events
-
Virtual Event – Addressing Unresolved Symptoms of Major Depressive Disorder
December 5 12:00 pm to 1:00 pm -
Virtual Event – Unmet Needs in Agitation Associated with Dementia Due to Alzheimer’s Disease
December 10 3:00 pm to 4:00 pm -
Virtual Event – Strategies to Optimize Patient Outcomes in Bipolar I Disorder
December 11 1:00 pm to 3:00 pm
Registration
Related Resources
-
Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)
On-Demand Webinar December 3, 2025In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.
-
Myths & Misconceptions: Bipolar Disorder
Podcast November 10, 2025Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.
-
Understanding the Complexity of Attention-Deficit Hyperactivity Disorder
On-Demand Webinar October 16, 2025Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…
Join today for instant access to all PsychU content, events, and more!
Membership is free!
"*" indicates required fields
Join PsychU Today to receive a wide array of tools and benefits
- Join our multidisciplinary community that is improving mental health care… together
- Quickly learn more about the topics you're interested in
- Access an award-winning library of on-demand mental health resources
- Gain key insights from industry expert & thought leaders
Stay Connected:


